rs61343376

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001114134.2(EPB42):​c.833-4A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00983 in 1,613,598 control chromosomes in the GnomAD database, including 1,101 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.048 ( 580 hom., cov: 32)
Exomes 𝑓: 0.0059 ( 521 hom. )

Consequence

EPB42
NM_001114134.2 splice_region, intron

Scores

2
Splicing: ADA: 0.0004688
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -1.16

Publications

2 publications found
Variant links:
Genes affected
EPB42 (HGNC:3381): (erythrocyte membrane protein band 4.2) Erythrocyte membrane protein band 4.2 is an ATP-binding protein which may regulate the association of protein 3 with ankyrin. It probably has a role in erythrocyte shape and mechanical property regulation. Mutations in the EPB42 gene are associated with recessive spherocytic elliptocytosis and recessively transmitted hereditary hemolytic anemia. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
EPB42 Gene-Disease associations (from GenCC):
  • hereditary spherocytosis type 5
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • hereditary spherocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 15-43208779-T-C is Benign according to our data. Variant chr15-43208779-T-C is described in ClinVar as Benign. ClinVar VariationId is 255157.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.158 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EPB42NM_001114134.2 linkc.833-4A>G splice_region_variant, intron_variant Intron 6 of 12 ENST00000441366.7 NP_001107606.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EPB42ENST00000441366.7 linkc.833-4A>G splice_region_variant, intron_variant Intron 6 of 12 1 NM_001114134.2 ENSP00000396616.2

Frequencies

GnomAD3 genomes
AF:
0.0475
AC:
7215
AN:
151944
Hom.:
571
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.161
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0157
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.0340
Gnomad SAS
AF:
0.00354
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000544
Gnomad OTH
AF:
0.0340
GnomAD2 exomes
AF:
0.0150
AC:
3739
AN:
249390
AF XY:
0.0119
show subpopulations
Gnomad AFR exome
AF:
0.162
Gnomad AMR exome
AF:
0.00579
Gnomad ASJ exome
AF:
0.00160
Gnomad EAS exome
AF:
0.0401
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000428
Gnomad OTH exome
AF:
0.00675
GnomAD4 exome
AF:
0.00589
AC:
8602
AN:
1461536
Hom.:
521
Cov.:
32
AF XY:
0.00532
AC XY:
3867
AN XY:
727060
show subpopulations
African (AFR)
AF:
0.166
AC:
5540
AN:
33474
American (AMR)
AF:
0.00731
AC:
327
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.00222
AC:
58
AN:
26132
East Asian (EAS)
AF:
0.0269
AC:
1067
AN:
39698
South Asian (SAS)
AF:
0.00378
AC:
326
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53290
Middle Eastern (MID)
AF:
0.00818
AC:
47
AN:
5746
European-Non Finnish (NFE)
AF:
0.000237
AC:
263
AN:
1111858
Other (OTH)
AF:
0.0161
AC:
974
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
475
950
1425
1900
2375
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
206
412
618
824
1030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0477
AC:
7252
AN:
152062
Hom.:
580
Cov.:
32
AF XY:
0.0450
AC XY:
3346
AN XY:
74352
show subpopulations
African (AFR)
AF:
0.162
AC:
6705
AN:
41462
American (AMR)
AF:
0.0156
AC:
238
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3468
East Asian (EAS)
AF:
0.0341
AC:
176
AN:
5164
South Asian (SAS)
AF:
0.00355
AC:
17
AN:
4794
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10590
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.000544
AC:
37
AN:
67982
Other (OTH)
AF:
0.0342
AC:
72
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.528
Heterozygous variant carriers
0
322
645
967
1290
1612
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
76
152
228
304
380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0235
Hom.:
137
Bravo
AF:
0.0549
Asia WGS
AF:
0.0480
AC:
166
AN:
3478
EpiCase
AF:
0.000709
EpiControl
AF:
0.000712

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 21, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary spherocytosis type 5 Benign:2
Nov 15, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.035
DANN
Benign
0.55
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00047
dbscSNV1_RF
Benign
0.0020
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61343376; hg19: chr15-43500977; API